In practice, intermittent peptide dosing can simulate natural pulses and resuscitate downstream hormone rhythms instead of crudely increasing levels

Pooled analysis reported no significant effect on not only total arrhythmia [RR=0.96, 95% CI (0.96, 1.05), p =0.36] ( Figure 2 ), but also its subtypes atrial fibrillation [RR=0.96, 95% CI (0.86, 1.07), p =0.43] ( Figure 3 ), atrial flutter [RR= 0.82, 95% CI (0.57, 1.19), p =0.30] ( Figure 3 ), atrial tachycardia [RR=0.64, 95% CI (0.20, 2.01), p =0.44)] ( Figure 3 ), sinoatrial node dysfunction [RR=0.74, 95% CI (0.44, 1.25), p =0.26] ( Figure 3 ), ventricular preterm systole [RR=1.42, 95% CI (0.62, 3.26), p =0.41] ( Figure 3 ), second degree AV block [RR=0.96, 95% CI (0.53, 1.72), p =0.88] ( Figure 3 ), complete AV block [RR=0.75, 95% CI (0.49, 1.17), p =0.21] ( Figure 3 ), ventricular fibrillation [RR=1.00, 95% CI (0.50, 2.02), p =1.00] ( Figure 3 ), ventricular tachycardia [RR=1.37, 95% CI (0.91, 2.08), p =0.13] ( Figure 3 ) from treatment with GLP-1RA versus placebo

Bednarz K, Kowalczyk K, Cwynar M (2022) The role of GLP-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome
BEST FOR
This product is manufactured to the highest quality standards and provides an easy way to complement your routine